
Cardiac Monitoring Devices Market Report 2026
Global Outlook – By Device Type (Electrocardiogram Monitors, Insertable Cardiac Monitors, Holter Monitors, Event Recorders, Mobile Cardiac Telemetry, Smart Wearables, Other Device Types), By Modality (Wired Devices, Wireless And Wearable Devices), By Age Group (Pediatric, Adult, Geriatric), By Application (Arrhythmia Detection, Atrial Fibrillation Monitoring, Heart Failure Management, Sports Cardiac Monitoring), By End User (Healthcare Providers, Diagnostic Laboratories, Research Institutes, Other End Users) – Market Size, Trends, Strategies, and Forecast to 2030
Cardiac Monitoring Devices Market Overview
• Cardiac Monitoring Devices market size has reached to $25.91 billion in 2025 • Expected to grow to $38.62 billion in 2030 at a compound annual growth rate (CAGR) of 8.2% • Growth Driver: The Rising Prevalence Of Cardiovascular Diseases Driving The Growth Of The Market Due To Unhealthy Lifestyle Habits • Market Trend: Innovative Wearable Solutions Strengthen Remote Heart Rhythm Detection • North America was the largest region in 2025 and Asia-Pacific is the fastest growing region.What Is Covered Under Cardiac Monitoring Devices Market?
Cardiac monitoring devices refer to medical devices used to continuously or intermittently monitor heart activity, including heart rate, rhythm, and electrical signals. The cardiac monitoring devices market is used to provide accurate and real-time cardiac data for diagnosis, treatment, and management of cardiovascular conditions across hospitals, clinics, and home care settings. The main device types of cardiac monitoring devices include electrocardiogram monitors, insertable cardiac monitors, Holter monitors, event recorders, mobile cardiac telemetry, smart wearables, and other device types. Electrocardiogram monitors refer to medical devices that continuously or intermittently record the electrical activity of the heart to detect abnormalities, assess cardiac function, and support clinical diagnosis. These devices are available as wired devices and wireless and wearable devices and are designed for pediatric, adult, and geriatric patients. The various applications involved are arrhythmia detection, atrial fibrillation monitoring, heart failure management, and sports cardiac monitoring and they are utilized by end users including healthcare providers, diagnostic laboratories, research institutes, and others.
What Is The Cardiac Monitoring Devices Market Size and Share 2026?
The cardiac monitoring devices market size has grown strongly in recent years. It will grow from $25.91 billion in 2025 to $28.15 billion in 2026 at a compound annual growth rate (CAGR) of 8.6%. The growth in the historic period can be attributed to increasing prevalence of cardiovascular diseases worldwide, growing aging population requiring cardiac care, rising adoption of cardiac monitoring devices in hospitals and clinics, expanding healthcare infrastructure development, increasing demand for early diagnosis and preventive cardiac care.What Is The Cardiac Monitoring Devices Market Growth Forecast?
The cardiac monitoring devices market size is expected to see strong growth in the next few years. It will grow to $38.62 billion in 2030 at a compound annual growth rate (CAGR) of 8.2%. The growth in the forecast period can be attributed to increasing demand for home-based cardiac monitoring solutions, growing adoption of wearable cardiac monitoring devices, rising healthcare digitization and remote patient monitoring services, expanding demand for personalized cardiac care solutions, increasing focus on continuous cardiovascular disease management. Major trends in the forecast period include increasing adoption of remote cardiac monitoring solutions for continuous patient care, growing demand for portable and wearable cardiac monitoring devices, rising focus on early detection and management of cardiovascular diseases, expansion of home based cardiac monitoring and decentralized healthcare services, increasing integration of advanced sensor technologies in cardiac monitoring devices.
Global Cardiac Monitoring Devices Market Segmentation
1) By Device Type: Electrocardiogram Monitors, Insertable Cardiac Monitors, Holter Monitors, Event Recorders, Mobile Cardiac Telemetry, Smart Wearables, Other Device Types 2) By Modality: Wired Devices, Wireless And Wearable Devices 3) By Age Group: Pediatric, Adult, Geriatric 4) By Application: Arrhythmia Detection, Atrial Fibrillation Monitoring, Heart Failure Management, Sports Cardiac Monitoring 5) By End User: Healthcare Providers, Diagnostic Laboratories, Research Institutes, Other End Users Subsegments: 1) By Electrocardiogram Monitors: Fixed Electrode Electrocardiogram Monitors, Portable Handheld Electrocardiogram Monitors, Wireless Remote Electrocardiogram Monitors, Twelve Lead Electrocardiogram Monitors 2) By Insertable Cardiac Monitors: Subcutaneous Insertable Cardiac Monitors, Intravascular Insertable Cardiac Monitors, Standard Duration Insertable Cardiac Monitors, Extended Duration Insertable Cardiac Monitors 3) By Holter Monitors: Twenty Four Hour Holter Monitors, Analog Holter Monitors, Digital Holter Monitors, Wireless Holter Monitors 4) By Event Recorders: External Event Recorders, Implantable Event Recorders, Continuous Event Recorders, Intermittent Event Recorders 5) By Mobile Cardiac Telemetry: Real Time Mobile Cardiac Telemetry Devices, Batch Transmission Mobile Cardiac Telemetry Devices, Automated Alert Mobile Cardiac Telemetry Devices, Continuous Monitoring Mobile Cardiac Telemetry Devices 6) By Smart Wearables: Smartwatch Cardiac Monitors, Chest Patch Cardiac Monitors, Armband Cardiac Monitors, Shirt Integrated Cardiac Monitors 7) By Other Device Types: Implantable Cardiac Defibrillator Monitors, Cardiac Resynchronization Therapy Monitors, Insertable Loop Recorders, Ambulatory Blood Pressure Cardiac MonitorsWhat Is The Driver Of The Cardiac Monitoring Devices Market?
The rising prevalence of cardiovascular diseases is expected to propel the growth of the cardiac monitoring devices market going forward. Cardiovascular diseases refer to a group of disorders that affect the heart and blood vessels, including conditions such as coronary artery disease, heart attack, stroke, and hypertension. The rising prevalence of cardiovascular diseases is due to unhealthy lifestyle habits such as poor diet, physical inactivity, smoking, and excessive alcohol consumption, along with increasing obesity, diabetes, stress, and an aging population. Cardiac monitoring devices enable early detection, continuous tracking, and timely clinical intervention in cardiovascular diseases by delivering real-time cardiac data that enhances diagnosis and treatment decisions. For instance, in October 2024, according to the Centers for Disease Control and Prevention, a US-based government agency, in 2023, cardiovascular disease claimed 919,032 lives, accounting for one in every three deaths. Coronary heart disease remained the most prevalent form of heart disease, and notably, about one in six deaths from cardiovascular diseases occurred among adults younger than 65 years. Therefore, the rising prevalence of cardiovascular diseases is driving the growth of the cardiac monitoring devices industry.Key Players In The Global Cardiac Monitoring Devices Market
Major companies operating in the cardiac monitoring devices market are Abbott Laboratories, AliveCor Inc., Asahi Kasei Corporation, Baxter International Inc., BIOTRONIK SE & Co. KG, BPL Medical Technologies Private Limited, Boston Scientific Corporation, Edwards Lifesciences Corporation, Fukuda Denshi Co. Ltd., GE HealthCare Technologies Inc., iRhythm Technologies Inc., Koninklijke Philips N.V., LivaNova PLC, Masimo Corporation, Medtronic plc, MicroPort Scientific Corporation, Nihon Kohden Corporation, Omron Healthcare Inc., OSI Systems Inc., Schiller AG, Shenzhen Mindray Bio-Medical Electronics Co. Ltd.
This chart is for illustrative purposes; the full report includes a detailed competitor analysis and comprehensive overview of the top 10 companies in the market.

This chart maps companies by product innovation and brand strength, with bubble size indicating relative revenue, helping identify market leaders, challengers, and niche players. This is an illustrative chart; the full report provides a complete and accurate competitive analysis.
Global Cardiac Monitoring Devices Market Trends and Insights
Major companies operating in the cardiac monitoring devices market are focusing on developing innovative products, such as wearable cardiac monitoring systems, to enhance continuous cardiac rhythm monitoring, improve diagnostic accuracy, and increase patient adherence. Wearable cardiac monitoring systems are compact medical devices designed to continuously record electrocardiogram (ECG) activity and wirelessly transmit cardiac data for clinical evaluation, providing a more convenient and efficient alternative to conventional Holter monitors that often require manual data retrieval and device return. For instance, in April 2026, RhythMedix, LLC, a US-based cardiac monitoring company, launched the RhythmStar SL cardiac monitor, a third-generation wearable cardiac monitoring device designed to improve patient experience and clinical performance. The device features a compact lead configuration, an IPX6-rated waterproof design, extended battery life, and built-in cellular connectivity that automatically transmits ECG data to the cloud without requiring patients to return the device for analysis. Additionally, when integrated with the company's Augmented Arrhythmia Intelligence platform, the monitor combines advanced detection algorithms with a multi-layered review process to provide accurate arrhythmia detection while supporting timely clinical decision-making.What Are Latest Mergers And Acquisitions In The Cardiac Monitoring Devices Market?
In December 2024 SmartCardia SA, a Switzerland-based medtech company, acquired Cardiomedix for an undisclosed amount. With this acquisition, SmartCardia aims to establish a fully integrated end-to-end cardiac monitoring ecosystem in the United States by combining its FDA-cleared wearable ECG technology and cloud analytics with Cardiomedix’s accredited diagnostic testing services to strengthen its clinical service delivery capabilities. Cardiomedix Inc. is a US-based company that provides both cardiac monitoring devices and remote monitoring services.
Regional Insights
North America was the largest region in the cardiac monitoring devices market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in this market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in this market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.What Defines the Cardiac Monitoring Devices Market?
The cardiac monitoring devices market consists of sales of products including electrocardiogram (ECG) devices, Holter monitors, event monitors, implantable loop recorders, cardiac telemetry devices, and wearable cardiac monitoring devices. Values in this market are ‘factory gate’ values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.How is Market Value Defined and Measured?
The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified). The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.
This chart presents market attractiveness based on a quantitative evaluation of growth, competition, strategic alignment, and risk, offering a clear view of opportunity areas for decision-making. This chart is for illustrative purposes; the full report contains the complete analysis.

This chart highlights the Total Addressable Market (TAM) by estimating the maximum revenue opportunity using an assumption-driven approach, supporting strategic planning and opportunity sizing across markets. The chart is illustrative; the full report provides a more comprehensive analysis.
What Key Data and Analysis Are Included in the Cardiac Monitoring Devices Market Report 2026?
The cardiac monitoring devices market research report is one of a series of new reports from The Business Research Company that provides market statistics, including industry global market size, regional shares, competitors with the market share, detailed market segments, market trends and opportunities, and any further data you may need to thrive in the cardiac monitoring devices industry. The market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future state of the industry.Cardiac Monitoring Devices Market Report Forecast Analysis
| Report Attribute | Details |
|---|---|
| Market Size Value In 2026 | $28.15 billion |
| Revenue Forecast In 2030 | $38.62 billion |
| Growth Rate | CAGR of 8.2% from 2026 to 2030 |
| Base Year For Estimation | 2025 |
| Actual Estimates/Historical Data | 2020-2025 |
| Forecast Period | 2026 - 2030 |
| Market Representation | Revenue in USD Billion and CAGR from 2026 to 2030 |
| Segments Covered | Device Type, Modality, Age Group, Application, End User |
| Regional Scope | Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa |
| Country Scope | The countries covered in the report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain. |
| Key Companies Profiled | Abbott Laboratories, AliveCor Inc., Asahi Kasei Corporation, Baxter International Inc., BIOTRONIK SE & Co. KG, BPL Medical Technologies Private Limited, Boston Scientific Corporation, Edwards Lifesciences Corporation, Fukuda Denshi Co. Ltd., GE HealthCare Technologies Inc., iRhythm Technologies Inc., Koninklijke Philips N.V., LivaNova PLC, Masimo Corporation, Medtronic plc, MicroPort Scientific Corporation, Nihon Kohden Corporation, Omron Healthcare Inc., OSI Systems Inc., Schiller AG, Shenzhen Mindray Bio-Medical Electronics Co. Ltd. |
| Customization Scope | Request for Customization |
| Pricing And Purchase Options | Explore Purchase Options |
